Pharmaceuticals

Growth In The Intranasal Corticosteroids Market Is Being Driven By Surgical Procedures Propel Growth Of The Antifibrinolytic Drug

April 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Intranasal Corticosteroids Market During The Forecast Period?

The intranasal corticosteroids market size has seen significant growth in recent years. It is projected to expand from $6.78 billion in 2025 to $7.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.8%. The historical growth of this market stemmed from limited awareness of intranasal corticosteroids, reliance on hospital pharmacies for drug distribution, a growing incidence of nasal allergies, a preference for conventional treatment methods, and restricted online pharmacy access.

The intranasal corticosteroids market is projected to experience robust expansion in the coming years. This market is anticipated to reach $9.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth during the forecast period include enhanced healthcare consciousness, the expansion of both retail and online pharmacy sectors, a higher occurrence of chronic rhinitis and nasal polyps, the integration of combination therapies, and the creation of user-friendly spray devices. Key trends expected within the forecast timeframe involve a growing prevalence of allergic rhinitis and various nasal disorders, a rise in the usage of prescribed intranasal corticosteroids, an increase in the application of over-the-counter intranasal corticosteroids, the broadening of hospital and homecare distribution networks, and an emphasis on patient-focused treatment alongside simplified administration.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25799&type=smp

Which Drivers Are Supporting The Intranasal Corticosteroids Market Growth?

The growing incidence of allergic rhinitis is anticipated to propel the expansion of the intranasal corticosteroids market moving forward. Allergic rhinitis is an allergic reaction that leads to inflammation of the nasal passages, commonly caused by airborne allergens such as pollen, dust mites, mold, or pet dander. The rise in allergic rhinitis cases is primarily attributed to increasing environmental pollution, which exposes individuals to airborne allergens and irritants that provoke allergic responses in the nasal passages. Intranasal corticosteroids assist in managing allergic rhinitis by reducing inflammation in the nasal passages, thereby alleviating symptoms like sneezing, congestion, and a runny nose. For instance, in October 2023, according to the National Library of Medicine, a US-based biomedical library, allergic rhinitis affects more than 400 million people worldwide, with prevalence rates estimated at 10% to 30% among adults and over 40% in children. Consequently, the increasing prevalence of allergic rhinitis is driving the intranasal corticosteroid market.

What Are The Key Segment Divisions In The Intranasal Corticosteroids Market Segment Structure?

The intranasal corticosteroids market covered in this report is segmented –

1) By Drug Types: Prescribed Drugs, Over-The-Counter Drugs

2) By Application: Allergic Rhinitis, Nasal Polyps, Sinusitis, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel

4) By End User: Hospitals, Clinics, Homecare, Healthcare Providers

Subsegments:

1) By Prescribed Drugs: Fluticasone Propionate, Mometasone Furoate, Budesonide, Beclomethasone Dipropionate, Ciclesonide

2) By Over-The-Counter Drugs: Triamcinolone Acetonide, Fluticasone Furoate, Budesonide Over-The-Counter Drugs

Which Trends Are Contributing To Changes In The Intranasal Corticosteroids Market?

Leading firms within the intranasal corticosteroids sector are prioritizing the creation of novel formulations, particularly nasal sprays, to optimize drug targeting and boost patient adherence. These liquid medications are administered straight into the nasal passages via a spray nozzle, addressing conditions like allergies, congestion, or inflammation. They facilitate rapid drug uptake through the nasal lining, providing prompt relief with limited systemic impact. An example is in March 2024, when OptiNose Inc., an American pharmaceutical firm, secured U.S. Food and Drug Administration (FDA) approval for XHANCE. This product represents the initial and sole treatment specifically indicated for adults experiencing chronic rhinosinusitis (CRS) lacking nasal polyps. This particular nasal spray employs a distinct exhalation delivery mechanism, allowing the medicine to penetrate deeply into the nasal cavity, thereby effectively managing CRS in adults, whether polyps are present or not. Each application provides 93 mcg of fluticasone propionate. The device functions by requiring the user to exhale into a mouthpiece while simultaneously dispensing the spray into the nostril, ensuring accurate administration and improved symptom alleviation.

Which Organizations Are Engaged In The Intranasal Corticosteroids Market?

Major companies operating in the intranasal corticosteroids market are GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Haleon plc, Intas Pharmaceuticals Limited, Organon Pharma (UK) Limited, Sun Pharmaceutical Industries Ltd., Apotex Inc., Perrigo Company plc, Aurobindo Pharma Limited, Cipla Ltd., Hikma Pharmaceuticals plc, Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Limited, OptiNose US Inc., Taro Pharmaceutical Industries Ltd., Maya Biotech Private Limited, AdvaCare Pharma USA, Lupin Ltd., Xenone Healthcare Private Limited.

Get The Full Intranasal Corticosteroids Market Report:

https://www.thebusinessresearchcompany.com/report/intranasal-corticosteroids-global-market-report

Which Region Leads The Intranasal Corticosteroids Market In Overall Market Size?

North America was the largest region in the intranasal corticosteroids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intranasal corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Intranasal Corticosteroids Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/intranasal-corticosteroids-global-market-report

Browse Through More Reports Similar to the Global Intranasal Corticosteroids Market 2026, By The Business Research Company

Internal Nasal Dilators Market Report 2026

https://www.thebusinessresearchcompany.com/report/internal-nasal-dilators-global-market-report

Corticosteroid Market Report 2026

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Intranasal Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795